(1S,2R)-1-(1-NAPHTHYL)-2-[(S)-1-AZIDOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
Compound with spectra: 1 NMR
![(1S,2R)-1-(1-NAPHTHYL)-2-[(S)-1-AZIDOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE](/api/compound/ETbFVIN0xnc.png?ph=true&h=300&w=458 "(1S,2R)-1-(1-NAPHTHYL)-2-[(S)-1-AZIDOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE")
| SpectraBase Compound ID | ETbFVIN0xnc |
|---|---|
| InChI | InChI=1S/C21H26N4O/c1-4-19(23-24-22)18-14-21(18,20(26)25(5-2)6-3)17-13-9-11-15-10-7-8-12-16(15)17/h7-13,18-19H,4-6,14H2,1-3H3/t18-,19-,21+/m0/s1 |
| InChIKey | WXZYEBUUTQAXSC-IRFCIJBXSA-N |
| Mol Weight | 350.47 g/mol |
| Molecular Formula | C21H26N4O |
| Exact Mass | 350.210661 g/mol |
| Enantiomer InChIKey | WXZYEBUUTQAXSC-SBHAEUEKSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
2-(Methoxymethoxy)-2-(methoxymethyl)-1(2H)-acenaphthylenone
(R)-(-)-2-BUTYL-2'-DICYCLOHEXYLPHOSPHINO-1,1'-BINAPHTHYL
acetamide, N-[4-[(5Z)-5-[[5-(2,3-dichlorophenyl)-2-furanyl]methylene]-2-imino-4-oxothiazolidinyl]-1,2,5-oxadiazol-3-yl]-
Ethyl cis-1-(benzo[b]thiophen-3-yl)-2-(4-methoxyphenyl)cyclopropane-1-carboxylate
KLQXMRBGMLHBBQ-LPJMJDIZSA-N
3-RHAMNOSYL-4-(3'-HYDROXY-4'-METHOXY-PHENYL-ETHEN-KETO)-6-XYLYL-GLUCOSE-3-HYDROXY-4-METHOXY-PHENYL)-ETHANOID
.alpha.,beta.-unsaturated Aldehyde
3-RHAMNOSYL-4-(3',4'-DIHYDROXYPHENYL-ETHENYL-KETO)-6-XYLYL-GLUCOSE-(3-HYDROXY-4-METHOXY)-PHENYLETHANOID
RPWWVBMXYOQTAE-VSVZXMTQSA-N
1,3,6,8-TETRACYClOPENTYLPYRENE-DICATION
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of derivatives of (1S,2R)-1-phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) modified at the 1-aromatic moiety as novel NMDA receptor antagonists: the aromatic group is essential for the activity | Bioorganic & Medicinal Chemistry | 2002 |